ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Clinical trials for ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial offers hope for Tough-to-Treat stomach cancers

Disease control Recruiting now

This study is testing if a new drug called JS107 works better than standard treatments for people with advanced stomach or gastroesophageal junction cancer that has a specific marker called CLDN18.2. It is for patients whose cancer has continued to grow after their first round of…

Matched conditions: ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Phase: PHASE3 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Get alerted when new ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

New drug trial offers hope for Tough-to-Treat stomach cancers